Keytruda is seeing usage in a lot of different cancers.
The potential auto-immune side-effects are generally minimal but progressive with increased usage. Quite different to traditional chemo side-effects.
The difficult part for ER people is recognizing these new treatment associated auto-immune symptoms, particularly if the patient doesn't mention they're on an immune mediating cancer therapy.
We've run out of other people's Social Security taxes needed to subsidize our low income tax rates.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.